Chitosan Grafted Polyacrylic Acid: Synthesis, Characterization, And Advanced Applications In Biomedical And Agricultural Systems

Molecular Architecture And Polyelectrolyte Complex Formation Of Chitosan Grafted Polyacrylic Acid

The fundamental structure of chitosan grafted polyacrylic acid involves either non-stoichiometric polyelectrolyte complexes (PECs) or covalently bonded graft copolymers. Chitosan, a linear polysaccharide composed of randomly distributed β-(1→4)-linked D-glucosamine (deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit), is derived from chitin through alkaline deacetylation 24. The degree of deacetylation typically ranges from 70% to 100%, directly influencing the density of primary amino groups available for interaction with polyacrylic acid 1518. Polyacrylic acid (PAA), a synthetic vinyl polymer with repeating carboxylic acid functional groups, exhibits strong anionic character in aqueous solutions above pH 4.5, enabling electrostatic attraction with protonated chitosan amino groups 12.

In polyelectrolyte complex formation, the interaction occurs through charge pairing between —NH₃⁺ groups on chitosan and —COO⁻ groups on polyacrylic acid, creating a three-dimensional network stabilized by ionic bonds, hydrogen bonding, and hydrophobic interactions 114. The stoichiometry of this complexation is non-stoichiometric, meaning the molar ratio of charged groups deviates from 1:1, resulting in materials with residual charges that contribute to pH-responsive swelling behavior 14. Patent literature describes these complexes as particularly useful for membrane and filtration applications due to their tunable porosity and mechanical integrity 1.

Covalent grafting approaches employ chemical coupling agents or radiation-induced polymerization to create permanent bonds between chitosan and polyacrylic acid chains. Ionizing radiation (gamma-ray or UV) generates free radicals on chitosan backbone, initiating graft polymerization of acrylic acid monomers 5. This method produces disordered copolymers or dual-grafted polymers with dense, porous structures that exhibit enhanced chemical stability across pH 3–9 5. Alternative synthesis routes include carbodiimide-mediated coupling, where carboxylic acid groups of PAA react with amino groups of chitosan in the presence of EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide) and NHS (N-hydroxysuccinimide), forming stable amide linkages 2.

The molecular weight of chitosan significantly impacts complex properties. High molecular weight chitosan (intrinsic viscosity ≥1.0 dL/g) is essential for gene delivery applications, as low molecular weight variants exhibit dramatically reduced transfection efficiency 6. For drug delivery systems, chitosan oligosaccharides with molecular weights below 200,000 Da and deacetylation degrees of 70–100% are preferred, offering improved solubility while maintaining functional group density for grafting 1518.

Synthesis Methodologies And Process Optimization For Chitosan-Polyacrylic Acid Grafts

Radiation-Induced Graft Polymerization

Radiation grafting represents a solvent-free, environmentally benign approach for synthesizing chitosan-g-polyacrylic acid. The process involves exposing chitosan substrates (films, nonwoven fabrics, or powders) to gamma radiation from Cobalt-60 sources or UV light (254–365 nm wavelength) in the presence of acrylic acid monomer 5. Radiation doses typically range from 10 to 50 kGy for gamma irradiation, with dose rate affecting grafting density and molecular weight distribution 5. The mechanism proceeds through:

1. Radical generation: Ionizing radiation cleaves C—H or C—O bonds in chitosan, creating macroradicals on the polymer backbone
2. Monomer activation: Acrylic acid monomers in contact with chitosan radicals undergo addition reactions
3. Chain propagation: Growing polyacrylic acid chains extend from chitosan grafting sites
4. Termination: Radical recombination or disproportionation halts chain growth

Critical process parameters include monomer concentration (typically 10–50 wt% in aqueous solution), irradiation time (5–60 minutes for UV, instantaneous for gamma), temperature (25–60°C), and atmosphere (nitrogen purging prevents premature termination) 5. Post-grafting purification involves extensive washing with deionized water and dilute acetic acid to remove homopolymer and unreacted monomer, followed by freeze-drying to preserve porous morphology 5.

Chemical Coupling And Carbodiimide-Mediated Grafting

For applications requiring precise control over grafting density and molecular architecture, carbodiimide chemistry offers advantages. The procedure involves:

1. Chitosan dissolution: Chitosan (1–3 wt%) is dissolved in dilute acetic acid (0.5–2 vol%) at pH 4.5–5.5, ensuring complete protonation of amino groups 2
2. PAA activation: Polyacrylic acid (Mw 50,000–250,000 Da) is dissolved separately in water, and carboxylic groups are activated using EDC (2–5 molar equivalents relative to —COOH) and NHS (1–2 equivalents) at pH 5.0–6.0 for 15–30 minutes 2
3. Coupling reaction: Activated PAA solution is added dropwise to chitosan solution under vigorous stirring at 4–25°C, maintaining pH 5.5–6.5 with phosphate buffer. Reaction proceeds for 4–24 hours 2
4. Purification: The product is dialyzed against water (MWCO 12,000–14,000 Da) for 48–72 hours with frequent water changes, then lyophilized 2

Grafting efficiency is quantified by elemental analysis (C/N ratio changes) or FTIR spectroscopy (amide I band at 1650 cm⁻¹ intensity increase). Typical grafting ratios range from 5% to 40% (weight of PAA per weight of chitosan), with higher ratios achieved by increasing EDC concentration or reaction time 2.

Emulsion And Dispersion Polymerization Techniques

For preparing chitosan-g-PAA nanoparticles or microparticles, emulsion polymerization provides size control and surface functionality. A representative protocol involves formulating an oil phase (mineral oil or liquid paraffin) and an aqueous phase containing chitosan (0.5–2 wt%), acrylic acid monomer (5–20 wt%), and initiator (ammonium persulfate, 0.1–0.5 wt%) 4. The phases are emulsified using surfactants (Span 80, Tween 80) at 8,000–15,000 RPM for 5–15 minutes, then polymerization is initiated by heating to 60–80°C for 2–6 hours under nitrogen 4. Particle size ranges from 100 nm to 10 μm depending on emulsifier concentration and stirring speed 4.

Physicochemical Properties And Structure-Function Relationships

pH-Responsive Swelling And Solubility Behavior

The amphoteric nature of chitosan-g-PAA complexes confers exceptional pH-responsive properties. At acidic pH (<4.5), both chitosan amino groups (pKa ~6.5) and PAA carboxylic groups (pKa ~4.5) are protonated, reducing electrostatic attraction and causing complex dissociation or swelling 213. Chitosan becomes soluble, while PAA remains collapsed. At neutral to slightly alkaline pH (6.0–8.0), strong ionic pairing occurs, forming compact, water-insoluble complexes with minimal swelling 2. At pH >8.5, chitosan deprotonates and PAA fully ionizes, leading to charge repulsion and maximum swelling 2.

Quantitative swelling studies demonstrate equilibrium swelling ratios of 5–15 g water/g polymer at pH 7.4, increasing to 30–80 g/g at pH 1.2 (simulated gastric fluid) for non-covalently complexed materials 2. Covalently grafted systems exhibit lower swelling (10–40 g/g at pH 1.2) due to permanent crosslinks restricting chain mobility 5. This pH-dependent swelling is exploited in oral drug delivery, where tablets remain intact in the stomach but swell and release payload in the intestine 2.

Mechanical Properties And Viscoelastic Characteristics

Mechanical strength of chitosan-g-PAA materials depends on grafting method, degree of crosslinking, and water content. Dry films prepared by solvent casting exhibit tensile strength of 40–80 MPa and elongation at break of 5–15%, comparable to low-density polyethylene 11. Hydrated hydrogels show elastic moduli of 1–50 kPa (measured by rheometry at 1 Hz, 1% strain), suitable for soft tissue contact applications 3. Puncture strength of chitosan-based films grafted with PAA reaches 0.8–1.5 N/mm, exceeding that of unmodified chitosan (0.4–0.6 N/mm) due to enhanced intermolecular interactions 11.

Dynamic mechanical analysis (DMA) reveals glass transition temperatures (Tg) of 80–120°C for dry chitosan-g-PAA, decreasing to 40–70°C in hydrated state due to plasticization by water 5. Storage modulus (E') at 37°C ranges from 10⁸ to 10⁹ Pa for dry materials and 10⁴ to 10⁶ Pa for hydrogels, indicating viscoelastic solid behavior 5.

Mucoadhesive Properties And Bioadhesion Mechanisms

Chitosan-g-PAA complexes exhibit superior mucoadhesion compared to either component alone, attributed to multiple interaction modes 2:

• Electrostatic attraction: Cationic chitosan binds to anionic sialic acid residues in mucin glycoproteins
• Hydrogen bonding: Hydroxyl and amino groups form H-bonds with mucin carbohydrates
• Chain interpenetration: Polymer chains diffuse into mucus gel network
• Hydrophobic interactions: Acetylated chitosan segments interact with mucin hydrophobic domains

In vitro mucoadhesion force measurements using porcine intestinal mucosa show detachment forces of 0.5–2.0 N for chitosan-g-PAA tablets, compared to 0.1–0.4 N for unmodified chitosan, representing 5–10-fold improvement 2. Ex vivo residence time studies in rat intestine demonstrate retention for 4–8 hours versus 1–2 hours for non-mucoadhesive controls 2. This prolonged contact enhances absorption of poorly permeable drugs and proteins.

Antimicrobial Activity And Mechanism Of Action

Chitosan inherently possesses antimicrobial properties through interaction with negatively charged bacterial cell membranes, causing membrane disruption and leakage of intracellular components 1719. Grafting with polyacrylic acid modulates this activity depending on pH and grafting density. At acidic pH, protonated chitosan segments exhibit enhanced bactericidal effects against Gram-positive bacteria (Staphylococcus aureus, Bacillus subtilis) with minimum inhibitory concentrations (MIC) of 50–200 μg/mL 17. Gram-negative bacteria (Escherichia coli, Pseudomonas aeruginosa) show higher resistance (MIC 200–500 μg/mL) due to outer membrane protection 17.

Quaternized chitosan-g-PAA derivatives, where amino groups are converted to permanent quaternary ammonium salts, display pH-independent antimicrobial activity with MIC values of 20–100 μg/mL against both Gram-positive and Gram-negative strains 1719. The mechanism involves electrostatic binding to bacterial surfaces, membrane penetration, and DNA/RNA binding, leading to cell death 17. Antifungal activity against Candida albicans and Aspergillus niger is observed at concentrations of 100–500 μg/mL 19.

Advanced Applications In Pharmaceutical And Biomedical Systems

Oral Drug Delivery And Mucoadhesive Formulations

Chitosan-g-PAA polyelectrolyte complexes address critical challenges in oral delivery of peptides, proteins, and poorly soluble drugs. The mucoadhesive properties prolong gastrointestinal residence time, while pH-responsive swelling enables site-specific release 2. A representative formulation for insulin delivery comprises:

• Core composition: Insulin (5–10 wt%), chitosan-g-PAA complex (60–80 wt%), excipients (lactose, microcrystalline cellulose) (10–30 wt%)
• Tablet preparation: Direct compression at 50–100 MPa or wet granulation followed by compression
• Coating: Optional enteric coating (Eudragit L100, hydroxypropyl methylcellulose phthalate) for gastric protection

In vitro release studies in simulated gastric fluid (pH 1.2) show <15% insulin release over 2 hours, while in simulated intestinal fluid (pH 6.8), 60–85% release occurs over 4–6 hours 2. Pharmacokinetic studies in diabetic rats demonstrate relative bioavailability of 8–15% compared to subcutaneous injection, representing significant improvement over unformulated insulin (<2%) 2. The mechanism involves:

1. Gastric protection: Compact complex structure at pH 1.2 prevents premature drug release and enzymatic degradation
2. Intestinal swelling: pH increase to 6.0–7.4 triggers complex dissociation and drug diffusion
3. Mucoadhesion: Prolonged contact with intestinal epithelium enhances paracellular transport
4. Permeation enhancement: Chitosan transiently opens tight junctions, increasing drug permeability by 3–8-fold 213

Clinical translation requires optimization of polymer molecular weight (chitosan: 50,000–200,000 Da; PAA: 100,000–250,000 Da), complexation ratio (1:0.5 to 1:2 chitosan:PAA by weight), and tablet hardness (40–80 N) to balance mucoadhesion and disintegration 2.

Gene Delivery And Transfection Systems

High molecular weight chitosan-g-PAA complexes serve as non-viral gene vectors, condensing plasmid DNA into nanoparticles (100–300 nm diameter) through electrostatic interaction 6. The grafting of polyacrylic acid introduces pH-buffering capacity, facilitating endosomal escape via the "proton sponge" effect 6. Optimal formulations utilize:

• Chitosan specifications: Intrinsic viscosity ≥1.0 dL/g, deacetylation degree 80–95%
• PAA grafting ratio: 10–30 wt%, molecular weight 50,000–100,000 Da
• N/P ratio: 5–20 (ratio of chitosan amino groups to DNA phosphate groups)
• Particle preparation: Mixing DNA solution (0.1–0.5 mg/mL) with chitosan-g-PAA solution (0.5–2 mg/mL) at pH 5.5–6.5, incubating 30 minutes at room temperature

Transfection efficiency in HEK293 and HeLa cells reaches 30–60% (percentage of cells expressing reporter gene), comparable to commercial lipofection reagents (Lipofectamine 2000: 40–70%) but with significantly lower cytotoxicity (cell viability >85% vs. 60–75%) 6. The PAA component enhances endosomal buffering, increasing pH from 5.0